An Observational Study of Cardiovascular Outcomes of Tirzepatide vs Glucagon-Like Peptide-1 Receptor Agonists.

JACC Adv · 2025 · PMC12235410 · PMID 40447342

Europe PMC DOI

hedged sentence

0.3400

closest p · 6.8× alpha

0.3400

boldest claim

The sentences

did not reach statistical significanceP = 0.34not close (p > 0.1)

Ischemic stroke events were less in adults on tirzepatide than in those on semaglutide/liraglutide but did not reach statistical significance (HR: 0.76, 95% CI: 0.43-1.34, P = 0.34).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.